Nilotinib
HealthData.Gov
Updated May 26, 2026
About this dataset
Nilotinib is a prescription oral capsule medication used to treat certain types of leukemia, such as chronic myeloid leukemia. It works as a kinase inhibitor, targeting specific enzymes involved in cancer cell growth. Available in 50mg, 150mg, and 200mg strengths, it is manufactured by Apotex Corp. under application ANDA203640. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Nilotinib
Access the FDA dataset for Nilotinib โ ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025